| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 17.34M | — |
| Operating expense | — | — |
| Net income | -81.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KURA returned +55.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +14.4% |
| 1 year | +55.4% |
| 5 years | -35.6% |
| 10 years | +106.1% |
| All-time high | $36.30 (Nov 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KURA would be worth today ›No. Kura Oncology, Inc. has not paid a dividend in the past 12 months.
Kura Oncology, Inc. stock trades on NASDAQ under the ticker symbol KURA.
Kura Oncology, Inc. is part of the Healthcare sector.
Kura Oncology, Inc. has a market cap of 1.06B USD, based on the latest quote.
Kura Oncology, Inc. is scheduled to report earnings on Nov 3, 2026.
